Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value: $1.673B (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 17,714,461 | $253M | 15.1% | $8.14 | — | Common | 452907108 |
| — | MIRATI THERAPEUTICS INC | 4,798,101 | $204M | 12.2% | $18.96 | — | Common | 60468T105 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,275,000 | $139M | 8.3% | $102.30 | +22.2% | Common | 803607100 |
| ASND | ASCENDIS PHARMA | 1,980,000 | $124M | 7.4% | $35.68 | — | Sponsored ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,360,000 | $116M | 6.9% | $86.03 | +10.6% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 10,125,000 | $97M | 5.8% | $10.29 | +6.8% | Common | 03152W109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 10,261,039 | $90.81M | 5.4% | $9.91 | -2.7% | Common | 462260100 |
| — | HORIZON PHARMA PLC | 4,350,000 | $85M | 5.1% | $13.49 | — | Common | G4617B105 |
| ARGX | ARGENX SE | 860,000 | $82.62M | 4.9% | $50.15 | — | Sponsored ADR | 04016X101 |
| — | AMARIN CORP PLC | 5,575,000 | $75.88M | 4.5% | $15.54 | — | Sponsored ADR | 023111206 |
| — | ZOGENIX INC | 1,975,000 | $72.01M | 4.3% | $37.38 | — | Common | 98978L204 |
| — | LOXO ONCOLOGY INC | 325,000 | $45.52M | 2.7% | $140.07 | — | Common | 548862101 |
| — | TRICIDA INC | 1,750,000 | $41.27M | 2.5% | $30.15 | — | Common | 89610F101 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,128,584 | $27.75M | 1.7% | $26.57 | 0.0% | Common | 019770106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 225,000 | $25.36M | 1.5% | $175.60 | -11.9% | Common | 558868105 |
| — | ASSEMBLY BIOSCIENCES INC | 1,000,000 | $22.62M | 1.4% | $28.06 | — | Common | 045396108 |
| TGTX | TG THERAPEUTICS INC | 4,750,000 | $19.48M | 1.2% | $9.62 | -48.4% | Common | 88322Q108 |
| — | INTEC PHARMA LTD | 2,500,000 | $18.85M | 1.1% | $8.29 | — | Common | M53644106 |
| — | BIODELIVERY SCIENCES INTL | 4,725,000 | $17.48M | 1.0% | $2.57 | — | Common | 09060J106 |
| PCRX | PACIRA PHARMACEUTICALS INC | 400,000 | $17.21M | 1.0% | $38.49 | +21.3% | Common | 695127100 |
| XENE | XENON PHARMACEUTICALS INC | 2,400,000 | $15.14M | 0.9% | $8.86 | +0.3% | Common | 98420N105 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 350,000 | $14.37M | 0.9% | $30.01 | — | Common | 37890U108 |
| PTCT | PTC THERAPEUTICS INC | 380,000 | $13.04M | 0.8% | $31.18 | +15.3% | Common | 69366J200 |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC | 475,000 | $13.03M | 0.8% | $25.66 | -4.7% | Common | G31249108 |
| — | TELIGENT INC | 5,300,000 | $7.261M | 0.4% | $7.35 | — | Common | 87960W104 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,105,999 | $7.056M | 0.4% | $11.09 | -37.0% | Common | 31447P100 |
| KOD | KODIAK SCIENCES INC | 902,200 | $6.406M | 0.4% | $8.85 | 0.0% | Common | 50015M109 |
| — | Y MABS THERAPEUTICS INC | 310,000 | $6.305M | 0.4% | $26.56 | — | Common | 984241109 |
| — | ALIMERA SCIENCES INC | 6,240,000 | $4.481M | 0.3% | $1.43 | — | Common | 016259103 |
| — | PROTEOSTASIS THERAPEUTICS INC | 1,300,000 | $4.212M | 0.3% | $3.24 | — | Common | 74373B109 |
| — | ACER THERAPEUTICS INC | 150,000 | $3.018M | 0.2% | $30.84 | — | Common | 00444P108 |
| — | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | $2.545M | 0.2% | $0.21 | — | Convertible Debt | 71426VAK4 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 500,000 | $1.44M | 0.1% | — | — | Call | 78464A870 |
| — | OUTLOOK THERAPEUTICS INC | 680,000 | $340K | 0.0% | $0.50 | — | Common | 69012T107 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 50,000 | $15,000 | 0.0% | — | — | Call | 64125C109 |